£1.31m
−45%vs Dec 2024Active13027523Private limited companyLondon
CS PHARMACEUTICALS LIMITED
Significant control: Steven Charles Andrew Harris (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Cs Pharmaceuticals Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Cs Pharmaceuticals Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
CS PHARMACEUTICALS LIMITED is an active private limited company (company number 13027523) incorporated on 18 November 2020, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 December 2025, showing net assets of £1.31m, with 6 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 45% on the prior period (£2.37m).
Peer position · net assets
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Mr Steven Charles Andrew Harris
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 18 November 20205 yrs ago
- Next accounts due
- 30 September 2027in 337 days
- Confirmation statement due
- 2 December 2026in 35 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
6
No changevs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £1.31m | — | — | — | — | — | 6 |
| 31 December 2024 | £2.37m | — | — | — | — | — | 6 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £1,312,617 at 31 December 2025
- Net assets down 25% or more on the prior period-44.6% vs prior period
- Incorporated five or more years agoIncorporated 18 November 2020
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 337 days
- Confirmation statement duein 35 days
- Accounts period endNet assets £1.31m · micro accounts
- Accounts period endNet assets £2.37m · micro accounts
- Incorporated
08
Similar companies in London
- BIOTECH SECURITY SERVICES GROUP LIMITEDLondon · inc. Nov 2020
- VIROCELL BIOLOGICS LTDLondon · inc. Nov 2020
- GROW TRADING LTDLondon · inc. Nov 2020
- GROW BIOTECH LTDLondon · inc. Nov 2020
- MANA BIOSYSTEMS LIMITEDLondon · inc. Nov 2020
- APEIKON THERAPEUTICS LTDLondon · inc. Dec 2020
All companies incorporated on 18 November 2020 · in Nov 2020.
09
Reminders for CS PHARMACEUTICALS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.